🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Membranous Nephropathy

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404EARLY Phase 11 site📍 Shanghai Nanjing Bioheng Biotech Co., Ltd. · Tests: RD06-05 CART Cell Injection A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites📍 Little Rock📍 Tustin📍 Gainesville Nkarta, Inc. · Tests: NKX019, Fludarabine, Cyclophosphamide China Kidney Patient Trials Network NCT05036850n/a1 site📍 Beijing George (Beijing) Clinical Research Co. Ltd. A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy NCT05668403Phase 16 sites📍 Zhengzhou📍 Shijiazhuang📍 Hangzhou Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B007, B007, B007 OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) NCT06781944Phase 31 site📍 Shanghai Huashan Hospital · Tests: Obinutuzumab, CTX combined with Glucocorticoids Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy NCT05839314Phase 41 site📍 Beijing Chinese PLA General Hospital · Tests: Huaier granule, Renin-angiotensin-aldosterone system inhibitors (RASI), Ciclosporin soft capsules Study of YK012 in Primary Membranous Nephropathy NCT06982729Phase 11 site📍 Beijing Excyte Biopharma Ltd · Tests: YK012 Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. NCT05505500n/a1 site📍 Ann Arbor University of Michigan · Tests: Interview Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) NCT06341205Phase 314 sites📍 Besançon📍 Bordeaux📍 Caen Centre Hospitalier Universitaire de Nice · Tests: RiTUXimab Injection Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy NCT07861204Phase 2, Phase 31 site📍 Beijing Peking University First Hospital · Tests: Rituximab combined with cyclosporine, rituximab Different Immunosuppressive Treatment in iMN NCT04745728Phase 31 site📍 Beijing Peking Union Medical College Hospital · Tests: Prednisone, Cyclophosphamide, Rituximab An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site📍 Bethesda National Human Genome Research Institute (NHGRI) · Tests: ManNAc A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy NCT07096843Phase 238 sites📍 Denver📍 Orlando📍 Atlanta Climb Bio, Inc. · Tests: budoprutug Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients NCT06038162NA12 sites📍 Bordeaux📍 Clermont-Ferrand📍 Dijon Hospices Civils de Lyon · Tests: Parallel connection, Integrated connection A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) NCT06962800Phase 3114 sites📍 Huntsville📍 Fresno📍 Los Angeles Biogen · Tests: Felzartamab, Tacrolimus, Standard of Care IST Anti-Glomerular Basement Membrane Disease NCT07018024n/a1 site📍 Lund Region Skane Immunopathological Analysis in a French National Cohort of Membranous Nephropathy NCT04326218NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Blood sample KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites📍 Chuncheon📍 Daegu📍 Seoul Seoul National University Hospital · Tests: Kidney Biopsy A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria NCT04456816Phase 21 site📍 Aarhus SynAct Pharma Aps · Tests: 100 mg AP1189, Placebo Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients NCT05117450NA1 site📍 Reims CHU de Reims · Tests: Decrease per-dialytic heparin therapy ASF Alport Patient Registry NCT06526741n/a1 site📍 Scottsdale Alport Syndrome Foundation · Tests: Longitudinal data collection Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane NCT06543940NA1 site📍 Bangkok Mahidol University · Tests: Vancomycin A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy NCT05696613Phase 331 sites📍 Los Angeles📍 San Dimas📍 Tarzana Cerium Pharmaceuticals, Inc. · Tests: SNP-ACTH (1-39) Gel, Rituximab Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site📍 Jinan Zunsong Wang · Tests: Imaging Time Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy NCT07266181Phase 11 site📍 Xi'an The First Affiliated Hospital of Air Force Medicial Univers… · Tests: All patients will receive CD19 CAR-T cell therapy on the basis of standard symptomatic and supportive treatment. Rivaroxaban in Idiopathic Membranous Nephropathy NCT07404436Phase 41 site📍 Beijing Beijing Friendship Hospital · Tests: Rivaroxaban 10 MG, Warfarin Sodium Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) NCT07157787Phase 240 sites📍 Loma Linda📍 San Diego📍 Minneapolis Alexion Pharmaceuticals, Inc. · Tests: ALXN1920, Placebo A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease NCT07571746Phase 227 sites📍 Los Angeles📍 Los Angeles📍 Iowa City AstraZeneca · Tests: Surovatamig
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy